Virtual Incision Corporation

Virtual Incision Corporation develops miniaturized robotic-assisted surgery (miniRAS) systems designed to democratize access to robotic-assisted surgery across healthcare facilities. The company's flagship product, the MIRA Surgical System, is the first FDA-cleared miniaturized robotic platform weighing approximately two pounds and deployable through a single abdominal incision. Unlike traditional mainframe robotic surgery systems, MIRA enables hospitals to perform robotic-assisted procedures in outpatient and ambulatory surgery centers, reducing capital barriers and expanding surgical capacity. The system is designed for general surgery abdominal procedures including colon resection and hysterectomy, with demonstrated remote surgical capabilities. Founded in 2006 by Dr. Dmitry Oleynikov and Dr. Shane Farritor, Virtual Incision holds over 200 patents and has raised more than $100 million in funding. The company's mission centers on making minimally invasive robotic surgery accessible to more patients, surgeons, and healthcare facilities by providing cost-effective alternatives to large-footprint robotic systems.